Italy
· Delayed Price · Currency is EUR Apellis Pharmaceuticals Statistics
Total Valuation
BIT:1APLS has a market cap or net worth of EUR 1.98 billion. The enterprise value is 2.08 billion.
| Market Cap | 1.98B |
| Enterprise Value | 2.08B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 125.68M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.96% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 84.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.76 |
| PB Ratio | 13.03 |
| P/TBV Ratio | 13.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.03 |
| EV / Sales | 2.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -266.86 |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 2.86.
| Current Ratio | 4.08 |
| Quick Ratio | 3.40 |
| Debt / Equity | 2.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | -55.83 |
| Interest Coverage | -4.19 |
Financial Efficiency
Return on equity (ROE) is -103.82% and return on invested capital (ROIC) is -23.06%.
| Return on Equity (ROE) | -103.82% |
| Return on Assets (ROA) | -14.20% |
| Return on Invested Capital (ROIC) | -23.06% |
| Return on Capital Employed (ROCE) | -29.61% |
| Revenue Per Employee | 1.01M |
| Profits Per Employee | -292,300 |
| Employee Count | 710 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.07 |
Income Statement
In the last 12 months, BIT:1APLS had revenue of EUR 717.81 million and -206.95 million in losses. Loss per share was -1.66.
| Revenue | 717.81M |
| Gross Profit | 291.14M |
| Operating Income | -172.29M |
| Pretax Income | -205.72M |
| Net Income | -206.95M |
| EBITDA | -170.62M |
| EBIT | -172.29M |
| Loss Per Share | -1.66 |
Balance Sheet
The company has 335.23 million in cash and 434.43 million in debt, giving a net cash position of -99.20 million.
| Cash & Cash Equivalents | 335.23M |
| Total Debt | 434.43M |
| Net Cash | -99.20M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 151.93M |
| Book Value Per Share | 1.21 |
| Working Capital | 508.25M |
Cash Flow
In the last 12 months, operating cash flow was -7.67 million and capital expenditures -109,174, giving a free cash flow of -7.78 million.
| Operating Cash Flow | -7.67M |
| Capital Expenditures | -109,174 |
| Free Cash Flow | -7.78M |
| FCF Per Share | n/a |
Margins
Gross margin is 40.56%, with operating and profit margins of -24.00% and -28.83%.
| Gross Margin | 40.56% |
| Operating Margin | -24.00% |
| Pretax Margin | -28.66% |
| Profit Margin | -28.83% |
| EBITDA Margin | -23.77% |
| EBIT Margin | -24.00% |
| FCF Margin | n/a |
Dividends & Yields
BIT:1APLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.96% |
| Shareholder Yield | -2.96% |
| Earnings Yield | -10.45% |
| FCF Yield | -0.39% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1APLS has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.4 |
| Piotroski F-Score | n/a |